SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ron Nairn who wrote (12079)2/8/2003 3:56:54 PM
From: Montana Wildhack   of 14101
 
Ron,

Great post. It's good to hear your thoughts again.

That this has not at all played out the way we thought
doesn't mean it will not play out at all.

In that sense just as Rebecca has shown she can be relied
on to be overly optimistic she can also be relied on to
continue fighting for success - despite some mistakes or
shortcomings.

She took the acqua route because the she kept thinking she
was closer to getting what she wants than she was. She
did listen to the shareholders and decided to go for a
larger amount from within the existing supporters. I suspect
she will continue to be frugal regardless and I expect this
offering when it is complete will remove cash concerns for
some reasonable time to come.

From my perspective neither the sky-is-falling nor the
rich-tommorrow group have been right or wrong. The bottom
line is we've been kept waiting with regard to what the
published brochure said, and what the revised brochure
said, and so on (refer to overly optimistic above).

Very true. But that only seriously matters to me if poor
timing predictions are combined with failures. I suggest
people who want to judge the UK go and look up what other
products Provalis sells, whether they're in direct
competition with Pennsaid, and what that timing was.

Personally I prefer Dimethaid to be perfect and seriously
I prefer several aspects of how Dimethaid handles things to
be greatly improved. Overall though I haven't seen DMX
land in the ditch the way some of the other previously
touted biotechs have. What I have is frustration from
waiting plus confirmation from many of the people around me
who suffer from arthritis that Pennsaid is an unbelievably
good product.

Currently that frustration is directed at not being able
to complete a rights offering in over 2 weeks. But its
completion will likely remove the cash issue for some time.
So I wait. I've become good at it.

Good post Ron.

Wolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext